Eva Benavent
YOU?
Author Swipe
View article: Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections
Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections Open
The efficacy, safety, and population pharmacokinetics of a single 1,500 mg dose of dalbavancin as a sequencing treatment for Gram-positive chronic prosthetic joint infections (CPJIs) have not been described. We present an observational, re…
View article: Risk factors for treatment failure in late acute periprosthetic joint infection in patients with rheumatoid arthritis treated with surgical debridement – a case-control study
Risk factors for treatment failure in late acute periprosthetic joint infection in patients with rheumatoid arthritis treated with surgical debridement – a case-control study Open
Background: Patients with rheumatoid arthritis (RA) with late acute periprosthetic joint infections (PJIs) treated with surgical debridement, antibiotics, and implant retention (DAIR) have a high failure rate. We conducted a case-control s…
View article: Comparative Efficacy of Continuous Ceftazidime Infusion vs. Intermittent Bolus against In Vitro Ceftazidime-Susceptible and -Resistant Pseudomonas aeruginosa Biofilm
Comparative Efficacy of Continuous Ceftazidime Infusion vs. Intermittent Bolus against In Vitro Ceftazidime-Susceptible and -Resistant Pseudomonas aeruginosa Biofilm Open
Background: As the anti-biofilm pharmacokinetic/pharmacodynamic (PK/PD) properties of antibiotics are not well-defined, we have evaluated the PK/PD indices for different regimens of ceftazidime (CAZ; with/without colistin) against Pseudomo…
View article: Cirugía Bariátrica en Régimen Ambulatorio: Evidencias de viabilidad y propuestas de implementación
Cirugía Bariátrica en Régimen Ambulatorio: Evidencias de viabilidad y propuestas de implementación Open
View article: Cutibacterium spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional Study
Cutibacterium spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional Study Open
Infection after spinal instrumentation (IASI) by Cutibacterium spp. is being more frequently reported. The aim of this study was to analyse the incidence, risk factors, clinical characteristics, and outcome of a Cutibacterium spp. IASI (CG…
View article: Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection
Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection Open
Background: Daptomycin-induced eosinophilic pneumonia (DEP) is a rare but severe adverse effect and the risk factors are unknown. The aim of this study was to determine risk factors for DEP. Methods: A retrospective cohort study was perfor…
View article: Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs
Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs Open
Background: To evaluate the efficacy and safety of long-term use of tedizolid in osteoarticular infections. Methods: Multicentric retrospective study (January 2017–March 2019) of osteoarticular infection cases treated with tedizolid. Failu…
View article: Lower Success Rate of Débridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study
Lower Success Rate of Débridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study Open
Background Surgical débridement, antibiotics and implant retention (DAIR) is currently recommended by international guidelines for both early acute (postsurgical) and late acute (hematogenous) periprosthetic joint infections (PJIs). Howeve…
View article: Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones
Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones Open
View article: Comparative Antibiofilm Efficacy of Meropenem Alone and in Combination with Colistin in an <i>In Vitro</i> Pharmacodynamic Model by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae
Comparative Antibiofilm Efficacy of Meropenem Alone and in Combination with Colistin in an <i>In Vitro</i> Pharmacodynamic Model by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Open
We compared the efficacies of meropenem alone and in combination with colistin against two strains of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae , using an in vitro pharmacodynamic model that mimicked two different biofi…
View article: Timing of implant-removal in late acute periprosthetic joint infection: A multicenter observational study
Timing of implant-removal in late acute periprosthetic joint infection: A multicenter observational study Open
View article: Invasive Meningococcal Disease: What We Should Know, Before It Comes Back
Invasive Meningococcal Disease: What We Should Know, Before It Comes Back Open
Background Invasive meningococcal disease (IMD), sepsis and/or meningitis continues to be a public health problem, with mortality rates ranging from 5% to 16%. The aim of our study was to further knowledge about IMD with a large series of …
View article: CLINICAL OUTCOME AND RISK FACTORS FOR FAILURE IN LATE ACUTE PROSTHETIC JOINT INFECTIONS TREATED WITH DEBRIDEMENT AND IMPLANT RETENTION
CLINICAL OUTCOME AND RISK FACTORS FOR FAILURE IN LATE ACUTE PROSTHETIC JOINT INFECTIONS TREATED WITH DEBRIDEMENT AND IMPLANT RETENTION Open
View article: Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention
Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention Open
View article: Late Acute Periprosthetic Joint Infections; When Should the Implant Be Removed?
Late Acute Periprosthetic Joint Infections; When Should the Implant Be Removed? Open
View article: Osteoarticular infection caused by MDR<i>Pseudomonas aeruginosa</i>: the benefits of combination therapy with colistin plus β-lactams
Osteoarticular infection caused by MDR<i>Pseudomonas aeruginosa</i>: the benefits of combination therapy with colistin plus β-lactams Open
We suggest that the BL/colistin combination is an optimized therapy for OI caused by MDR P. aeruginosa, together with an appropriate surgical treatment.